Russell Investments Group
NGNE icon

Russell Investments Group’s Neurogene NGNE Stock Holding History

Russell Investments Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Buy
5,990
+4,383
+273% +$121K ﹤0.01% 3200
2026
Q1 		$32.4K Buy
1,607
+751
+88% +$14.5K ﹤0.01% 3465
2025
Q4 		$17.6K Hold
856
– – ﹤0.01% 3656
2025
Q3 		$14.8K Buy
856
+815
+1,988% +$16.4K ﹤0.01% 3686
2025
Q2 		$613 Buy
+41
New +$643 ﹤0.01% 3727
2018
Q2 		– Sell
-89
Closed -$25K – 2937
2018
Q1 		$25K Sell
89
-111
-56% -$30.7K ﹤0.01% 2867
2017
Q4 		$46K Buy
+200
New +$46.9K ﹤0.01% 2876

Other funds holding NGNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Russell Investments Group's NGNE Position: Q2 2026 in Review

Russell Investments Group increased its Neurogene (NGNE) stake by 273% in Q2 2026, buying an estimated $121K and bringing the position to 5,990 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Russell Investments Group first reported a position in NGNE in Q4 2017 and has held it in 7 quarters since. 29 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Russell Investments Group held 5,990 shares of Neurogene worth $188K as of Q2 2026.
  • Russell Investments Group bought 4,383 Neurogene shares in Q2 2026, an estimated $121K.
  • Neurogene made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3200 holding.
  • Russell Investments Group first reported a position in Neurogene in Q4 2017 and has held it in 7 quarters since.
  • 29 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.